Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

10:32am EDT
Change (% chg)

$0.02 (+0.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ARRY.OQ


Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer. The Company’s wholly owned clinical stage drugs include Filanesib in Phase II clinical trials, is indicated for Kinesin spindle protein (KSP), inhibitor... (more)


Beta: 1.73
Market Cap(Mil.): $1,090.41
Shares Outstanding(Mil.): 141.06
Dividend: --
Yield (%): --


  ARRY.OQ Industry Sector
P/E (TTM): -- 312.37 38.84
EPS (TTM): -0.15 -- --
ROI: -4.85 -5.21 16.53
ROE: -45.75 -6.13 17.62
Search Stocks

BUZZ-Array BioPharma Inc: Eight-month high on Novartis deal

** Drug developer's shares rise as much as 24 pct to eight-month high of $4.84, the biggest intra-day jump in four-and-half years

04 Dec 2014

BUZZ-Array BioPharma Inc: Regains rights to cancer drug from Novartis

** Reaches agreement with Swiss drugmaker Novartis to regain rights to experimental cancer drug, binimetinib, currently being evaluated in three late-stage trials

03 Dec 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks